Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CVS Renames ProCare

This article was originally published in The Pink Sheet Daily

Executive Summary

CVS is changing the name of its specialty pharmacy business CVS ProCare to PharmaCare Specialty Pharmacy

You may also be interested in...



CVS To Close 200-225 Eckerd Stores; Number Is Fewer Than Expected, Retailer Says

The chain has held “introductory meetings” with Eckerd workers; the acquisition of 1,260 stores is expected to close in June. The Eckerd Health Services PBM could help revitalize CVS’ PharmaCare division, which experienced flat growth in the first quarter.

Natrecor Use Should Be Limited, Independent Panel Convened By J&J Says

The cardiologist panel calls for use of the congestive heart failure therapy to be "strictly limited" to patients that present with symptoms in the hospital setting. The expert panel also recommends that Scios "immediately undertake" a professional educational campaign about Natrecor's appropriate uses.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059185

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel